by Ragaviveka Gopalan, BSc, MS; Himanshi Pande, BA; Saralya Narayanan, BSc; and Adith Chinnaswami, MS, MBBS Ms. Gopalan and Dr. Chinnaswami are with MediSim VR in Chennai, India. Ms. Pande
Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. The authors have no conflicts of interest relevant to the contents of this letter. No funding was received for the preparation of this letter.
Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. The authors have no conflicts of interest relevant to the contents of this letter. No funding was received for the preparation of this letter.
Innov Clin Neurosci. 2024;21(1–3):8–9. Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter.
by Jonathan R. Scarff, MD Dr. Scarff is with Lexington Veterans Affairs Medical Center in Lexington, Kentucky. Funding: No funding was provided for this study. Disclosures: The author has no
by Muhammad Hassan Majeed, MD; Ali Ahsan Ali, MD; Hafiza Ayesha Khalil, MD; Douglas Bacon, MD; and Hafiz Muhammad Imran, MD Dr. Majeed is with the Department of Anesthesiology and
by Tina J. Wang, MD; Kyungje Sung; Marilyn Wilburn, MD; and Jace Allbright, DPT Dr. Wang is Attending Physician at Loma Linda Veterans Administration Hospital in the Department of Physical
by Muhammad Hassan Majeed, MD; Muhammad Ubaidulhaq, MD; Anesh Rugnath, MD; and Ike Eriator, MD Dr. Majeed is Attending Psychiatrist with the Department of Psychiatry at Natchaug Hospital in Norwich,
Innov Clin Neurosci. 2018;15(5–6):11–12 Dr. Majeed is an attending psychiatrist with Department of Psychiatry, Natchaug Hospital in Norwich, Connecticut. Dr. Ubaidulhaq is a Pain Medicine Fellow and Dr. Gusa Attending
by Brian Chau, MD; Ivan Phelan, MS; Phillip Ta, MD; Sarah Humbert, MD; Justin Hata, MD; and Duc Tran, MD, PhD Dr. Chau, Dr. Ta, Dr. Humbert, Dr. Hata, and
by David R. Spiegel, MD; Alexander Pattison, MD; Alexis Lyons, MD; Umer Ansari, MD; Aidan L. Mccroskey, MD; Eric Luehrs MD; Lauren Barr, BS; and Stephanie Le, MD All authors
by Julieta Dascal, BA; Mark Reid, PhD; Waguih William Ishak, MD, FAPA; Brennan Spiegel, MD, FACG; Jennifer Recacho, MA; Bradley Rosen, MD; and Itai Danovitch, MD, MBA All authors are
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
Dear Editor: Atypical long-acting injectable (LAI) antipsychotics may improve treatment options for patients with serious mental illnesses, such as schizophrenia and bipolar disorder.[1] A systematic review of 1,700 outpatients from
by Murali K. Kolikonda, MD; Suneela Cherlopalle, MD; Manasa Enja, MD; and Steven Lippmann, MD Drs. Kolikonda, Cherlopalle, Enja, and Lippmann are with the University of Louisville School of Medicine,
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine
Randy A. Sansone, MD; Daron A. Watts, MD; and Michael W. Wiederman, PhD Dr. Sansone is a Professor in the Departments of Psychiatry and Internal Medicine at Wright State University
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
